Treatment of severe complications of Fontan circulation with Endothelin1 dual (A and B) receptor antagonist Bosentan

被引：0
|
作者：
Milanesi, O. [1 ]
Scarabeo, V. [2 ]
Maschietto, N. [1 ]
Biffanti, R. [1 ]
Patuelli, G. [3 ]
机构：
[1] Dolo Hosp, Dept Cardiol, Dolo, Ve, Italy
[2] P Cosma Hosp, Dept Cardiol, Camposampiero, Pd, Italy
[3] Actel Pharmaceut Italy, Dept Med, Imola, Bo, Italy
来源：
EUROPEAN HEART JOURNAL | 2009年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：808 / 808
页数：1
相关论文
共 50 条
  • [1] Bosentan: a dual endothelin receptor antagonist
    Rubin, LJ
    Roux, S
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (07) : 991 - 1002
  • [2] Clinical pharmacology of bosentan, a dual endothelin receptor antagonist
    Dingemanse, J
    van Giersbergen, PLM
    CLINICAL PHARMACOKINETICS, 2004, 43 (15) : 1089 - 1115
  • [3] Clinical Pharmacology of Bosentan, a Dual Endothelin Receptor Antagonist
    Jasper Dingemanse
    Paul L. M. van Giersbergen
    Clinical Pharmacokinetics, 2004, 43 : 1089 - 1115
  • [4] Influence of severe renal dysfunction on the pharmacokinetics and metabolism of bosentan, a dual endothelin receptor antagonist
    Dingemanse, J
    van Giersbergen, PLM
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2002, 40 (07) : 310 - 316
  • [5] THE EFFECT OF THE ENDOTHELIN-1 DUAL RECEPTOR ANTAGONIST, BOSENTAN, ON PLATELET FUNCTION
    Wort, S. J.
    Davidson, S.
    Corte, T. J.
    Park, J.
    Harries, C.
    Gatzoulis, M.
    THORAX, 2008, 63 : A54 - A54
  • [6] Bosentan, a dual endothelin receptor antagonist, activates the pregnane X nuclear receptor
    van Giersbergen, PLM
    Gnerre, C
    Treiber, A
    Dingemanse, J
    Meyer, UA
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 450 (02) : 115 - 121
  • [7] Successful treatment of patients with severe secondary Raynaud's phenomenon with the endothelin receptor antagonist bosentan
    Selenko-Gebauer, N.
    Duschek, N.
    Minimair, G.
    Stingi, G.
    Karlhofer, F.
    RHEUMATOLOGY, 2006, 45 : 45 - 48
  • [8] Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)
    Riccardi, M. T.
    Chiala, A.
    Iannone, F.
    Grattagliano, V.
    Covelli, M.
    Lapadula, G.
    REUMATISMO, 2007, 59 (02) : 135 - 139
  • [9] The dual endothelin receptor antagonist bosentan inhibits migration of human monocytes in vitro
    Desole, S.
    Vogelsinger, H.
    Cima, K.
    Kaehler, C. M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2007, 119 (17-18) : A16 - A16
  • [10] Bosentan, a dual endothelin receptor antagonist, is a mild inducer of the metabolism of simvastatin.
    Dingemanse, J
    Schaarschmidt, D
    van Giersbergen, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P45 - P45
12345